Therapies

Five therapeutic divisions, chosen deliberately.

Denvia develops and commercialises a focused portfolio, produced through qualified third-party manufacturers. Products and therapeutic divisions sit at the centre of both the doctor and trade experience: doctors verify them, trade partners source, stock and support them.

Cardio-Metabolic

Antihypertensive, lipid-management and diabetes-related prescription therapies for long-term, everyday care.

Emphasis on long-term availability, formulation clarity and continuity of supply for chronic-care regimens.

Prescriber information available on request

Dermatology

Premium topical and oral formulations, including antifungal and other clinician-directed dermatology products.

Dosage form, strength and pack are presented clearly to support confident, day-to-day prescribing.

Prescriber information available on request

Gastroenterology

Acid-peptic, motility and digestive-health prescription formulations across common gastrointestinal conditions.

Composition and release type are clearly distinguished so equivalent-looking products are never confused.

Prescriber information available on request

Anti-Infectives

Clinician-directed antimicrobial products for prescriber-led management of bacterial and fungal infections.

Presented through antimicrobial-stewardship-conscious, prescriber-directed language rather than promotion.

Prescriber information available on request

Pain Management

Clinician-directed analgesic and anti-inflammatory products for acute and chronic pain presentations.

Presented with balanced benefit-risk and safety language, consistent with responsible prescribing.

Prescriber information available on request

Product-level detail

Exact composition, strength, dosage form, pack and referenced medical information are available to healthcare professionals through Medical Information.

Visit Medical Information

Denvia products are prescription medicines. Availability and indications vary by market and are subject to local regulatory approval.

Portfolio development

Additional therapeutic areas under evaluation for future expansion.

Respiratory CareIn development
Neurology & CNSIn development
Women's HealthIn development
Urology & NephrologyIn development

These areas are not yet active. A division moves from development to launch only once its portfolio, documentation and approved copy have been verified.